Skip to main content

BCR-ABL-1 Synthesis Inhibitor

BCR-ABL-1 synthesis inhibitors are used to treat chronic myeloid leukemia. They work by preventing cancer cells from multiplying and spreading.

Why are bcr abl 1 synthesis inhibitor prescribed?

  1. Leukemia (100%)

Key takeaways

BCR-ABL-1 synthesis inhibitors are used to treat chronic myeloid leukemia (CML). These medications work by blocking the production of BCR-ABL and MCL-1 proteins, which cause cancer cells to grow and survive. One example is an injection called Synribo (omacetaxine), but it's been discontinued by its manufacturer.

Prices for popular BCR-ABL-1 Synthesis Inhibitor medications
Viewing 1 of 1 medications
vial icon

Synribo

OMACETAXINE treats leukemia. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
See pricesMore info
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Subscribe and save

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men's health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

Browse medications

View All
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.
ABCDEFGHIJKLMNOPQRSTUVWXYZ